![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Kainos, Towa Conclude Sales Agreement on Influenza Virus Detection Reagent
Kainos, Towa Conclude Sales Agreement on Influenza Virus Detection Reagent
Kainos Laboratories announced on June 7 that it has signed a sales agreement with Towa Pharmaceutical, one of the leading Japanese generic drug manufacturers, on Statmark Influenza A/B, Kainos' proprietary influenza virus detection kit co-developed with Nichirei. Under the terms of the agreement, Kainos and Towa will collaborate in sales targeting general practitioners nationwide.
()a href="http://www.japancorp.net/Article.Asp?Art_ID=10267" target="_blank">Japan Corporate News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct